MDT
Medtronic Plc
NYSE · Healthcare · Medical - Devices · IE
$92.77
−2.09%Aug 25, 2026, 21:45 UTC
Medtronic's stock fell 1.81% to $91.22 in the latest session, underperforming the S&P 500's 0.32% gain.
Aug 22, 2026, 07:10 UTC
Alpine Woods Capital Investors LLC acquired a new stake in Medtronic PLC, purchasing 68,491 shares valued at approximately $5.36 million, according to a recent SEC filing.
Source:Aug 20, 2026, 20:50 UTC
Medtronic plc's board of directors approved a cash dividend of $0.72 per ordinary share for the second quarter of fiscal year 2027.
Source:Aug 20, 2026, 17:15 UTC
Medtronic's MiniMed Flex insulin pump system, paired with Abbott's 15-day Instinct sensor, is now shipping in the United States.
Source:Aug 6, 2026, 11:00 UTC
Medtronic announced an expanded CE Mark indication for its Affera Mapping and Ablation System with Sphere-9 Catheter to treat ventricular arrhythmias, including ventricular tachycardia and premature ventricular complexes.
Source:Aug 5, 2026, 19:30 UTC
A federal jury in Boston ordered Medtronic to pay $88 million to Larry Patterson and his wife in the first trial over hernia mesh made by Medtronic's Covidien unit, finding the company failed to warn about dangers.
Jul 31, 2026, 08:30 UTC
CoreMap raised $37 million in an oversubscribed Series C financing round, with participation from Medtronic.
Source:Jul 31, 2026, 04:30 UTC
Aer Lingus announced it will end flights to Minneapolis-Saint Paul International Airport in October 2026, after serving the route since 2019.
Source:Jul 27, 2026, 14:28 UTC
MiniMed (MMED) obtained Medicare coverage for its Flex insulin pump and automated insulin delivery technology, broadening diabetes care access for Medicare beneficiaries.
Source:Jul 21, 2026, 11:00 UTC
Medtronic unveiled Touch Surgery Aide, an AI-native surgical computing platform, at the Society of Robotic Surgery 2026 conference.
Jul 20, 2026, 21:45 UTC
A lawsuit was filed in Florida federal court by plaintiff Christine Hunter against Medtronic, alleging that a defective Medtronic MiniMed insulin pump caused her to fall into a diabetic coma.
Source:Jul 17, 2026, 10:56 UTC
Olympus announced the appointment of Brian Barry, currently at Medtronic, as Chief Quality and Regulatory Officer (CQO) effective August 1, to address FDA warnings over quality management issues.
Source:Jul 16, 2026, 13:00 UTC
Medtronic completed its acquisition of SPR Therapeutics, Inc.
Source:Jul 3, 2026, 10:00 UTC
Medical technology giant Medtronic suffered a data breach in April 2026, when the extortion group ShinyHunters accessed its corporate IT systems, compromising the personal and medical information of over 3.8 million individuals.
Jul 1, 2026, 00:00 UTC
Omnicell, Inc. appointed Nnamdi Njoku as President and Chief Operating Officer, effective June 2026.
Source:Jun 12, 2026, 15:00 UTC
Medtronic completed its acquisition of Scientia Vascular for $550 million.
Source:Jun 9, 2026, 17:41 UTC
Medtronic plc announced its intention to acquire SPR Therapeutics, Inc. for approximately $650 million in cash.
Source:Jun 8, 2026, 16:05 UTC
Medtronic received FDA 510(k) clearance for its Nellcor pulse oximetry system with Nell-EQ intelligent processor.
Jun 8, 2026, 11:41 UTC
The U.S. Food and Drug Administration approved Medtronic's Hugo robotic-assisted surgery platform for urologic procedures in December 2025.
Source:Jun 5, 2026, 13:39 UTC
Medtronic launched its Stealth AXiS robotic system for spine, cranial, and ENT surgeries in April 2025, with rollout in Kentucky, Virginia, West Virginia, and California.
Source:Jun 5, 2026, 01:56 UTC
Medtronic reported fiscal fourth-quarter adjusted earnings of $1.55 per share and revenue of $9.8 billion, exceeding analyst expectations.
Jun 4, 2026, 10:34 UTC
CereVasc, Inc. completed an $85 million Series C financing led by Piper Sandler Merchant Banking with participation from Johnson & Johnson Innovation – JJDC, Inc., Medtronic, and existing investors.
Source:Jun 3, 2026, 11:05 UTC
Medtronic submitted 510(k) filings to expand the Hugo robotic-assisted surgery system into general and gynecologic specialties in the United States.
Source:Jun 3, 2026, 00:00 UTC
Medtronic plc reported Q4 fiscal 2026 financial results with revenue of $9.807 billion and GAAP diluted EPS of $0.96.
← PreviousPage 2